Concussion News and Research

RSS

Amarantus demonstrates excellent diffusion profile of MANF in the striatum of rat brains

Amarantus BioSciences, Inc., a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has successfully completed experiments demonstrating that MANF has an excellent diffusion profile in the striatum of rat brains.

27 Nov 2012

$Study identifies fractional anisotropy as predictor of brain damage after TBI$

Study identifies fractional anisotropy as predictor of brain damage after TBI

Using a special magnetic resonance imaging (MRI) technique to image patients with mild traumatic brain injury (MTBI), researchers have identified a biomarker that may predict which patients will do well over the long term, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

26 Nov 2012

MRI reveals changes in brains of people with post-concussion syndrome

MRI shows changes in the brains of people with post-concussion syndrome (PCS), according to a new study published online in the journal Radiology. Researchers hope the results point the way to improved detection and treatment for the disorder.

21 Nov 2012

Telemedicine program shows promise for patients with concussions in rural Arizona

A program at Mayo Clinic using telemedicine technology is showing promise for patients with concussions in rural Arizona. A case study published in the December 2012 issue of Telemedicine and e-Health validates "teleconcussion" as a useful means to assess concussed patients.

19 Nov 2012

Study evaluates benefits of HBO2 therapy on post-concussion symptoms in military personnel with TBI

The average incidence of traumatic brain injury (TBI) among service members deployed in Middle East conflict zones has increased 117% in recent years, mainly due to proximity to explosive blasts. Therapeutic exposure to a high oxygen environment was hoped to minimize the concussion symptoms resulting from mild TBI, but hyperbaric oxygen (HBO2) treatment may not offer significant advantages, according to an article in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

14 Nov 2012

Teleconcussion for diagnosis and management of mild TBI in athletes

Concussion is a common disorder estimated to affect no fewer than 1.7-3.8 million people in the U.S. each year. Many more people with concussion likely do not seek medical care for symptoms of concussion and may suffer long-lasting, progressive, and profoundcognitive, psychiatric, and neurologic effects.

9 Nov 2012

New U-M mobile phone app for concussion patients

A new mobile phone app, the first of its kind, helps concussion patients track their activities and symptoms, and share that information with their healthcare team. The app from the University of Michigan, is called Return2Play.

24 Oct 2012

Amarantus acquires option to license LymPro Alzheimer's diagnostic blood test from MDx

Amarantus BioSciences, Inc., a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptotis therapeutic protein MANF, today announced that it has acquired an exclusive option to license the LymPro Alzheimer's Diagnostic Blood Test from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, LLC.

11 Oct 2012

Study identifies need for better definitions and diagnostic tools for sports head injuries

In recent years it has become clear that athletes who experience repeated impacts to the head may be at risk of potentially serious neurological and psychiatric problems. But a study of sports programs at three major universities, published in the October 2 Journal of Neurosurgery, finds that the way the injury commonly called concussion is usually diagnosed - largely based on athletes' subjective symptoms - varies greatly and may not be the best way to determine who is at risk for future problems.

11 Oct 2012

Rainbow, Amarantus report joint venture agreement for NuroPro Parkinson's diagnostic platform

Rainbow Coral Corp. biotech subsidiary Rainbow BioSciences and Amarantus Biosciences have moved into the final stages of the terms for a deal. The pending joint venture agreement will see the two entities working together to move the Amarantus NuroPro Parkinson's diagnostic platform towards commercialization.

8 Oct 2012

Longer looks: In-depth in the ER; Brains are saved as high school football season begins

Eric Morgan, in his 20s and planning to get married, arrives at Highland Hospital's emergency room, shaken that he has been diagnosed with a testicular tumor that is likely cancer. Surgeons at a private hospital have turned him away for lack of insurance but tell him it's "urgent" he get care.

28 Sep 2012

X2IMPACT, NFL enter agreement to supply Concussion Management System software app

X2IMPACT, a privately funded Seattle company, today announced that it has entered into an agreement with the National Football League to supply its Concussion Management System (CMS) software application for use by certain teams of the NFL during the 2012 football season.

25 Sep 2012

Fifth Military Vision Research Symposium to take place from Sept. 18-20

Eye injuries in war have changed - and increased in number - as weapons, tactics, technology and strategies have evolved. Today's soldiers face threats from explosive devices that cause extensive damage areas not protected by body armor. Military experts and ophthalmologists from the Schepens Eye Research Institute, Massachusetts Eye and Ear will convene in Boston, Mass., on Sept. 18 to address these issues at the Fifth Military Vision Research Symposium.

15 Sep 2012

Rusk to host community events in recognition of National Rehabilitation Awareness Week

Rusk Rehabilitation at NYU Langone Medical Center (Rusk) will host a series of community events in recognition of National Rehabilitation Awareness Week, September 16-22.

14 Sep 2012

UNH faculty member to continue research into implications of football equipment

NFL Charities, the charitable foundation of the National Football League owners, has awarded a grant to University of New Hampshire faculty member Erik Swartz to further his ongoing research on the implications of football helmet, facemask, and shoulder pad design on emergency care for injured players.

13 Sep 2012

Nationwide Children's Hospital introduces Concussion ToolKit for student-athletes

According to a recent study by the Centers for Disease Control and Prevention, a concussion sends students to the emergency room every five minutes in this country.

13 Sep 2012

UB researchers receive NFL grant for sports-related medical research on concussion

After sustaining a concussion, when can an athlete safely return to play? That's the primary question for professional and amateur athletes alike. Now, University at Buffalo sports medicine researchers have been awarded $100,000 from NFL Charities to develop the most objective, scientific method of determining when an athlete who has had a concussion can safely return to play.

12 Sep 2012

American footballers at high risk for neurodegenerative death

Professional American Football players are significantly more likely to die from a neurodegenerative disease than the general public, say US researchers.

10 Sep 2012

Concussion: an interview with Dr Rob Reid

Concussion happens when something produces a concussive force to the head, such as a blow to the head. The definition from the 2008 consensus, which was in Zurich, is, “concussion is defined as a complex pathophysiological process affecting the brain, induced by traumatic biomechanical forces.”